Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance
- 11 June 2015
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 8 (7) , 682-689
Abstract
Cannabis smoking increases motor vehicle accident risk. Empirically defined cannabinoid detection windows are important to drugged driving legislation. Our aims were to establish plasma cannabinoid detection windows in frequent cannabis smokers and to determine if residual cannabinoid concentrations were correlated with psychomotor performance. Twenty‐eight male chronic frequent cannabis smokers resided on a secure research unit for up to 33 days with daily blood collection. Plasma specimens were analyzed for Δ9‐tetrahydrocannabinol (THC), 11‐hydroxy‐THC (11‐OH‐THC), and 11‐nor‐9‐carboxy‐THC (THCCOOH) by gas chromatography‐mass spectrometry. Critical tracking and divided attention tasks were administered at baseline (after overnight stay to ensure lack of acute intoxication) and after 1, 2, and 3 weeks of cannabis abstinence. Twenty‐seven of the twenty‐eight participants were THC‐positive at admission (median 4.2 µg/L). THC concentrations significantly decreased 24 h after admission, but were still ≥2 µg/L in 16 of the 28 participants 48 h after admission. THC was detected in 3 of 5 specimens on day 30. The last positive 11‐OH‐THC specimen was 15 days after admission. THCCOOH was measureable in 4 of 5 participants after 30 days of abstinence. Years of prior cannabis use significantly correlated with THC concentrations on admission, and days 7 and 14. Tracking error, evaluated by the Divided Attention Task, was the only evaluated psychomotor assessment significantly correlated with cannabinoid concentrations at baseline and day 8 (11‐OH‐THC only). Median THC was 0.3 µg/L in 5 chronic frequent cannabis smokers’ plasma samples after 30 days of sustained abstinence. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.Keywords
Funding Information
- National Institute on Drug Abuse
- National Institute of Mental Health
This publication has 48 references indexed in Scilit:
- Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving LawsClinical Chemistry, 2013
- Psychomotor Function in Chronic Daily Cannabis Smokers during Sustained AbstinencePLOS ONE, 2013
- Marijuana Use and Motor Vehicle CrashesEpidemiologic Reviews, 2011
- Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokersMolecular Psychiatry, 2011
- An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive FunctionsJournal of Addiction Medicine, 2011
- Do Δ9‐tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?Addiction, 2009
- Extended urinary Δ9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposureDrug and Alcohol Dependence, 2009
- Intra- and Intersubject Whole Blood/Plasma Cannabinoid Ratios Determined by 2-Dimensional, Electron Impact GC-MS with CryofocusingClinical Chemistry, 2009
- Simultaneous quantification of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometryJournal of Chromatography A, 2007
- Do cognitive impairments recover following cessation of cannabis use ?Life Sciences, 1995